Medplus Health Services Limited · NSE: MEDPLUS · BSE: 543427
Medplus Health Services
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 21 Jul 2026.
Q1 FY27 · Consolidated
Revenue
1,879.60₹ Cr
+21.8% vs year ago
Net profit
33.17₹ Cr
−21.7% vs year ago
EPS, basic
2.76₹
−22.0% vs year ago
Net margin
1.8%
−1.0 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 1,879.60 | +21.8% | 33.17 | −21.7% | 2.76 | 21 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 1,864.38 | +23.5% | 63.97 | +24.7% | 5.33 | 20 May 2026 |
| Q3 FY26Oct–Dec 2025 | 1,806.12 | +15.7% | 57.79 | +26.0% | 4.82 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 1,679.33 | +6.5% | 55.50 | +43.4% | 4.63 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1,542.63 | +3.6% | 42.34 | +195.2% | 3.54 | 07 Nov 2025 |
| Q4 FY25Jan–Mar 2025 | 1,509.61 | +1.3% | 51.32 | +52.9% | 4.32 | 07 Nov 2025 |
| Q3 FY25Oct–Dec 2024 | 1,561.45 | +8.3% | 45.87 | +234.7% | 3.84 | 31 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 1,576.17 | +11.9% | 38.70 | +166.1% | 3.24 | 13 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 1,488.83 | +15.9% | 14.34 | +281.0% | 1.20 | 05 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 1,490.50 | +19.0% | 33.56 | +26.4% | 2.81 | 29 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,441.47 | +21.1% | 13.71 | +2.4% | 1.15 | 03 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 1,408.59 | +25.7% | 14.54 | +124.5% | 1.22 | 11 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,284.30 | +29.2% | 3.77 | +2.3% | 0.32 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 1,252.98 | +29.7% | 26.56 | +132.4% | 2.24 | 26 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,190.31 | +27.5% | 13.38 | −20.9% | 1.12 | 06 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 1,120.62 | — | 6.48 | — | 0.55 | 24 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 993.65 | — | 3.68 | — | 0.27 | 06 Sep 2022 |
| Q4 FY22Jan–Mar 2022 | 965.91 | — | 11.43 | — | 0.99 | 13 Jun 2022 |
| Q3 FY22Oct–Dec 2021 | 933.45 | — | 16.92 | — | 1.53 | 17 Feb 2022 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 222.64 | +21.1% | 17.45 | +29.0% | 1.45 | 21 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 248.04 | +22.9% | 16.67 | +19.2% | 1.39 | 20 May 2026 |
| Q3 FY26Oct–Dec 2025 | 223.00 | +26.1% | 16.58 | +76.9% | 1.38 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 205.65 | +31.6% | 15.63 | +101.8% | 1.31 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 183.88 | +3.1% | 13.53 | +46.2% | 1.13 | 07 Nov 2025 |
| Q4 FY25Jan–Mar 2025 | 201.75 | +36.0% | 13.98 | +41.0% | 1.17 | 07 Nov 2025 |
| Q3 FY25Oct–Dec 2024 | 176.79 | +19.4% | 9.37 | +193.9% | 0.78 | 31 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 156.23 | +58.3% | 7.75 | Turned profit | 0.65 | 13 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 178.33 | +148.0% | 9.26 | Turned profit | 0.77 | 05 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 148.37 | +70.6% | 9.92 | +73.8% | 0.83 | 29 May 2024 |
| Q3 FY24Oct–Dec 2023 | 148.10 | +158.7% | 3.19 | +414.2% | 0.27 | 03 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 98.67 | +132.4% | (0.04) | Loss narrowed | 0.05 | 11 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 71.89 | +163.5% | (3.48) | Turned loss | (0.29) | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 86.95 | +124.0% | 5.71 | +519.0% | 0.15 | 26 May 2023 |
| Q3 FY23Oct–Dec 2022 | 57.24 | +131.6% | 0.62 | Turned profit | 0.15 | 06 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 42.45 | — | (0.82) | — | (0.07) | 24 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 27.29 | — | 0.04 | — | 0.00 | 06 Sep 2022 |
| Q4 FY22Jan–Mar 2022 | 38.82 | — | 0.92 | — | 0.08 | 13 Jun 2022 |
| Q3 FY22Oct–Dec 2021 | 24.71 | — | (1.21) | — | (0.11) | 17 Feb 2022 |
38 filings on record for this company.